Anika Therapeutics, Inc. (ANIK) stock
ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$12.92−0.48 (-3.58%)
Close on Nov 16, 2026Market cap $172.91MP/E –Yield –
Anika Therapeutics EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Anika Therapeutics's EV/EBITDA was 296.6× on Nov 11, 2026, against 14.7× a year earlier. Over the last 5 years it ranged from 5.5× to 483.9×, with a median of 16.6×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 296.6× | +223.5 |
| 2025 | Apr 30, 2025 | 73.0× | +67.5 |
| 2024 | Dec 31, 2024 | 5.5× | −198.9 |
| 2023 | Oct 31, 2023 | 204.4× | +154.7 |
| 2022 | Jul 29, 2022 | 49.8× | +33.7 |
| 2020 | Oct 30, 2020 | 16.1× | +3.6 |
| 2019 | Dec 31, 2019 | 12.6× | +0.5 |
| 2018 | Dec 31, 2018 | 12.1× | +0.0 |
| 2017 | Dec 29, 2017 | 12.1× | +1.9 |
| 2016 | Dec 30, 2016 | 10.2× | +0.8 |
| 2015 | Dec 31, 2015 | 9.4× | +1.5 |
| 2014 | Dec 31, 2014 | 7.9× | −6.2 |
| 2013 | Dec 31, 2013 | 14.1× | +9.0 |
| 2012 | Dec 31, 2012 | 5.0× | −2.5 |
| 2011 | Dec 30, 2011 | 7.6× | −0.1 |
| 2010 | Dec 31, 2010 | 7.7× | – |
See a number that looks wrong?